Last updated: October 2, 2024
Sponsor: Heinrich-Heine University, Duesseldorf
Overall Status: Active - Recruiting
Phase
N/A
Condition
Prostate Cancer
Prostate Cancer, Early, Recurrent
Urologic Cancer
Treatment
PSA testing
Clinical Study ID
NCT06626386
006
Ages 45-70 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Men aged from 45 to 70 years
Informed consent for PSA measurement for prostate cancer screening
Exclusion
Exclusion Criteria:
- Patients unable to give consent
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: PSA testing
Phase:
Study Start date:
June 01, 2024
Estimated Completion Date:
October 31, 2024
Study Description
Connect with a study center
Klinik für Urologie, Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia 40225
GermanyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.